BioCentury
ARTICLE | Finance

Third Rock keeps its options open

Why Third Rock likes multi-asset option deals for its newcos

December 20, 2018 11:04 PM UTC

Third Rock Ventures is cementing its strategy to create newcos that can succeed as stand-alone companies. The VC has ditched the build-to-buy model in favor of one that gives a pharma broad options to multiple programs.

The idea is to bring in a pharma early on, and give it options to multiple products from the biotech’s platform, rather than the entire biotech. ...